2019
DOI: 10.1016/j.tifs.2019.03.023
|View full text |Cite
|
Sign up to set email alerts
|

Physiological functionalities and mechanisms of β-glucans

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
43
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 124 publications
(52 citation statements)
references
References 152 publications
1
43
0
1
Order By: Relevance
“…The highest expression of Caspase-3 protein was observed in the control group fed with feed supplemented with high-molar-mass oat beta-glucans (HβGh+), which indicates the beneficial effect of this beta-glucan fraction in this respect. The physical properties of high-molar-mass beta-glucans favor the formation of a protective layer on the inner wall of the intestine, and hence this beta-glucan fraction effectively supports the development of beneficial microbiota producing short-chain fatty acids which favor the faster regeneration of epithelium damaged by saline administration [ 23 , 41 , 42 ].…”
Section: Discussionmentioning
confidence: 99%
“…The highest expression of Caspase-3 protein was observed in the control group fed with feed supplemented with high-molar-mass oat beta-glucans (HβGh+), which indicates the beneficial effect of this beta-glucan fraction in this respect. The physical properties of high-molar-mass beta-glucans favor the formation of a protective layer on the inner wall of the intestine, and hence this beta-glucan fraction effectively supports the development of beneficial microbiota producing short-chain fatty acids which favor the faster regeneration of epithelium damaged by saline administration [ 23 , 41 , 42 ].…”
Section: Discussionmentioning
confidence: 99%
“…Food Marketing Industry data showed that the global β‐glucan market was worth $307.8 million in 2016 with a prediction by Markets and Markets to reach $476.5 million in 2022. [ 142 ] Yestimun is the only β‐glucan that has attempted to hold a European Food Safety Authority (EFSA) health claim in regard to immunity; however, it received a negative response when applying for the health claim “initiation of appropriate innate and adaptive immune responses in adults” in 2009 at a dose of 0.45 g twice daily. The EFSA Panel on Dietetic Products, Nutrition, and Allergies concluded that cause and effect relationship could not be established between the consumption of Yestimun and the initiation of appropriate innate and adaptive immune responses due to the existence of contradicting results in the literature.…”
Section: Dietary Regulations and Emerging Areas Of Researchmentioning
confidence: 99%
“…An important element of IBD treatment is pharmacotherapy, which is accompanied by modification of the diet. The beneficial dietary factors recommended in IBD diet therapy include soluble fractions of dietary fiber, which include among others cereal beta-glucans [10].…”
Section: Introductionmentioning
confidence: 99%